The microRNA miR-30a blocks adipose tissue fibrosis accumulation in obesity
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci175566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Pradip K Saha und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine and. Hauptthemen laut MEDLINE: MicroRNAs, Obesity, Adipose Tissue, White. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
White adipose tissue (WAT) fibrosis occurring in obesity contributes to the inflammatory and metabolic comorbidities of insulin resistance and type 2 diabetes, yet the mechanisms involved remain poorly understood. Here, we report a role for the broadly conserved miRNA miR-30a as a regulator of WAT fibrosis and systemic glucose metabolism. Mice modified to express miR-30a at elevated levels in adipose tissues maintain insulin sensitivity coupled with reduced fatty liver disease when fed a high-fat diet. These effects were attributable to cell-autonomous functions of miR-30a that potently increase expression of adipocyte-specific genes. Proteomic screening revealed miR-30a limits profibrotic programs in subcutaneous WAT, at least in part, by repressing PAI-1, a dominant regulator of fibrinolysis and biomarker of insulin resistance. Conversely, mouse adipocytes lacking miR-30a exhibited greater expression of fibrosis markers with disrupted cellular metabolism. Lastly, miR-30a expression negatively correlates with PAI-1 levels in subcutaneous WAT from people with obesity, further supporting an antifibrotic role for miR-30a . Together, these findings uncover miR-30a as a critical regulator of adipose tissue fibrosis that predicts metabolically healthy obesity in people and mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine and.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
- Center for Metabolic and Degenerative Diseases, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Advanced Technology Core Labs and.
- Department of Biochemistry, Baylor College of Medicine, Houston, Texas, USA.
- Department of Anesthesiology, Critical Care, and Pain Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Texas, USA.
Förderung
- NIDDK NIH HHS
- NIA NIH HHS
- NCI NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Aging
- American Diabetes Association
Zitieren
APA
Saha, P. K., Sharp, R., Cox, A. R., Habib, R., Bolt, M. J., Felix, J. B., Ramirez Bustamante, C. E., Li, X., Jung, S. Y., Kim, K. H., Sun, K., Wu, H., Klein, S., & Hartig, S. M. (2025). The microRNA miR-30a blocks adipose tissue fibrosis accumulation in obesity. Journal of Clinical Investigation. https://doi.org/10.1172/jci175566
Vancouver
Saha PK, Sharp R, Cox AR, Habib R, Bolt MJ, Felix JB, et al. The microRNA miR-30a blocks adipose tissue fibrosis accumulation in obesity. Journal of Clinical Investigation. 2025. doi:10.1172/jci175566
BibTeX
@article{Saha2025,
author = {Saha, Pradip K and Sharp, Robert and Cox, Aaron R and Habib, Rabie and Bolt, Michael J and Felix, Jessica B and Ramirez Bustamante, Claudia E and Li, Xin and Jung, Sung Yun and Kim, Kang Ho and Sun, Kai and Wu, Huaizhu and Klein, Samuel and Hartig, Sean M},
title = {The microRNA miR-30a blocks adipose tissue fibrosis accumulation in obesity},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci175566}
}
EUVIMED